Management of Neurogenic Lower Urinary Tract Dysfunction in Multiple Sclerosis Patients
| Autor: | Benjamin M. Brucker, Areeba Sadiq |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Urologic Diseases
Nephrology medicine.medical_specialty Botulinum Toxins Multiple Sclerosis Urology Urinary system Vibration Internal medicine medicine Animals Humans Effective treatment Screening tool Intensive care medicine business.industry Multiple sclerosis Treatment options General Medicine medicine.disease Botulinum toxin Neuromodulation (medicine) Exercise Therapy Surgery Treatment Outcome business medicine.drug |
| Zdroj: | Current Urology Reports. 16 |
| ISSN: | 1534-6285 1527-2737 |
| DOI: | 10.1007/s11934-015-0519-5 |
| Popis: | Multiple sclerosis (MS) can be a debilitating neurological condition that attributes significant morbidity to bladder dysfunction. Although many effective treatment options exist, symptomatic patients are often underdiagnosed and undertreated. The purpose of this article is to give an overview of the current literature including new screening tools to identify symptomatic patients and updates on treatment options including medications, botulinum toxin, and neuromodulation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink